CERT
Certara Inc

706
Mkt Cap
$978.71M
Volume
6.49M
52W High
$15.38
52W Low
$6.04
PE Ratio
-597.09
CERT Fundamentals
Price
$6.15
Prev Close
$6.38
Open
$6.37
50D MA
$7.73
Beta
1.13
Avg. Volume
3.39M
EPS (Annual)
-$0.0099
P/B
0.92
Rev/Employee
$265,760.15
$1,529.13
Loading...
Loading...
News
all
press releases
Protagonist Therapeutics (PTGX) Soars 4.7%: Is Further Upside Left in the Stock?
Protagonist Therapeutics (PTGX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Certara, Inc. $CERT Stock Position Boosted by Kopion Asset Management LLC
Kopion Asset Management LLC boosted its holdings in Certara, Inc. (NASDAQ:CERT - Free Report) by 49.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities...
MarketBeat·2d ago
News Placeholder
Topline Capital Management LLC Purchases Shares of 546,471 Certara, Inc. $CERT
Topline Capital Management LLC acquired a new position in shares of Certara, Inc. (NASDAQ:CERT - Free Report) in the third quarter, according to its most recent disclosure with the Securities and...
MarketBeat·8d ago
News Placeholder
Alpha Wave Global LP Takes Position in Certara, Inc. $CERT
Alpha Wave Global LP acquired a new position in Certara, Inc. (NASDAQ:CERT - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange...
MarketBeat·8d ago
News Placeholder
Certara Conference: 2025 revenue hits guidance, EBITDA margin tops range as Q4 software bookings slip
Certara (NASDAQ:CERT) closed 2025 with results that Chief Financial Officer John Gallagher described as strong on revenue and profitability, while acknowledging mixed bookings trends and continued...
MarketBeat·8d ago
News Placeholder
Certara Details 2026 Outlook at Leerink Conference as Software Bookings Slow, AI Push Builds
Certara (NASDAQ:CERT) executives used a discussion at the Leerink Partners global healthcare conference to outline recent performance, the assumptions behind the company's outlook, and the priorities...
MarketBeat·8d ago
News Placeholder
Dixon Mitchell Investment Counsel Inc. Purchases Shares of 866,380 Certara, Inc. $CERT
Dixon Mitchell Investment Counsel Inc. acquired a new stake in shares of Certara, Inc. (NASDAQ:CERT - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·12d ago
News Placeholder
Certara, Inc. (NASDAQ:CERT) Receives Consensus Recommendation of "Hold" from Brokerages
Certara, Inc. (NASDAQ:CERT - Get Free Report) has received an average rating of "Hold" from the fourteen brokerages that are presently covering the firm, MarketBeat reports. One investment analyst...
MarketBeat·13d ago
News Placeholder
Certara CEO Resnick Teases Regulatory Services Decision, Phoenix Cloud Push at TD Cowen Conference
Certara (NASDAQ:CERT) executives used a fireside chat at the TD Cowen Health Care Conference to outline early priorities under new CEO Jon Resnick, discuss the company's ongoing strategic review of...
MarketBeat·14d ago
News Placeholder
Certara's (CERT) Equal Weight Rating Reiterated at Barclays
Barclays reissued an "equal weight" rating and issued a $8.00 price objective on shares of Certara in a report on Friday...
MarketBeat·16d ago
<
1
2
...
>

Latest CERT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.